Antibody Generation with Beacon
Meet our team of experts in antibody discovery, assay development, flow cytometry, immunology, and antibody generation with single B cell cloning using the Beacon® Optofluidic System.
Beacon
Antibody Discovery with Beacon® Single B Cell Cloning
At ChemPartner, as the first CRO adopter of the Beacon® Optofluidic System, we take immense pride in providing faster and unparalleled single B cell cloning solutions through this revolutionary technology. Our commitment to excellence and our dedication to optimizing the antibody discovery and antibody generation process sets us apart in the industry.
The Beacon® system has revolutionized single B cell cloning, but its success hinges on the expertise of the team operating it. Our highly experienced and skilled scientists form the backbone of our success because the intricacies of the single B cell antibody discovery process demand meticulous attention to detail. Without optimized reagents, assays, and processes, the final run risks failure. This is why our team invests significant effort upfront to maximize success rates. We understand that precision and accuracy are paramount to delivering top-notch results to our clients.
Let us be your Beacon® to success. Our expert team is ready to show you the impact of precision and efficiency in your research. Contact our team today!
Meet the Beacon® Team
Beacon’s learning curve is both long and steep. To ensure that our clients receive the highest level of expertise and efficiency, we have assembled a dedicated team of scientists solely focused on running projects with the Beacon®. Their unwavering commitment and familiarity with the machine allow us to navigate even the most complex challenges with confidence. Our expertise expedites your research success.
Andreas Loos, PhD
Director, Biologics Discovery
Andreas Loos, PhD, joined ChemPartner in 2021 as the Director of Biologics Discovery and he currently leads the biologics discovery team at ChemPartner’s South San Francisco site. The team was one of the first adopters of Beacon® technology and has successfully used the platform since 2019 to conduct antibody discovery projects.
Prior to joining ChemPartner, Dr. Loos led an antibody discovery and assay development group at Aridis Pharmaceuticals. During his PhD and post-doctoral training in Gent (Belgium), Heidelberg (Germany), and Vienna (Austria), he studied production and post-translational modifications of biologics in plants.
Neha Yevalekar, MS
Senior Scientist
Neha Yevalekar, MS, joined ChemPartner in 2019 as Senior Scientist in the biologics discovery group and currently leads several antibody discovery projects.
Prior to joining the team at ChemPartner, Neha led production, identification, and characterization of therapeutics antibodies for immune-oncology targets; additionally, led the cell line development, assay development, and B cell cloning platform at Compugen & Intrexon.
During her MS at California State University (USA) and her Internships, she studied hybridoma, phage display, cell line generation, antibody engineering, protein expression, purification, and characterization using cell and molecular biology tools and techniques.
Emil H. Palacios, PhD
Principal Scientist
Emil H. Palacios, PhD, joined ChemPartner in 2020 as a Senior Scientist in the biologics discovery group and he currently leads antibody discovery projects and novel technologies development.
Prior to joining ChemPartner, Dr. Palacios led and supported the development of protein detection assays and nucleic acid diagnostics for in-house use as well as IVD submissions in immunology and infectious disease models.
During his PhD and post-doctoral training at the University of California, San Francisco (USA), he elucidated the roles of protein tyrosine signaling kinases in immunological development and evaluated the function of T-lymphocytes in parasitic worm infections.
Mohammad E. Kabir, PhD
Scientist
Mohammad E. Kabir, PhD, joined ChemPartner in 2021 as Scientist in biologics discovery and currently is involved in the antibody discovery team using the Beacon® single B cell cloning platform.
Prior to joining ChemPartner, Dr. Kabir handled the production, identification, and characterization of customized monoclonal antibodies at Abcam. During his PhD and post-doctoral training in Niigata (Japan), the University of Michigan (USA), the University of Texas at Austin (USA), and Tulane University (USA), he studied phage display, antibody engineering, protein expression, purification, and characterization using several biochemistry and molecular biology tools and techniques.
Jake Miller, BA
Senior RA
Jacob Miller joined ChemPartner in September of 2022 as a Senior Research Associate on the biologics discovery team in San Fransisco.
Prior to joining ChemPartner, Jake was a member of the antibody development team at R&D Systems and the Diagnostic Immunology team at Beckman Coulter.
Dedicated Beacon® Experts
Animal Species for Antibody Discovery
Beacon Publications
Combined Training Hours
Headquarters
1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203
Contact Us
China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000